2.Studies on Therapeutic Effects and Pathological Features of an Antithrombin Preparation in Septic Disseminated Intravascular Coagulation Patients.
Yuichiro SAKAMOTO ; Satoshi INOUE ; Takashi IWAMURA ; Tomoko YAMASHITA ; Atsushi NAKASHIMA ; Yoichi NISHIMURA ; Hiroyuki KOAMI ; Hisashi IMAHASE ; Akiko GOTO ; Kosuke Chris YAMADA ; Kunihiro MASHIKO ; Hiroyuki YOKOTA
Yonsei Medical Journal 2013;54(3):686-689
PURPOSE: Few reports have been made on the therapeutic effects as well as pathological features of an antithrombin preparation in patients diagnosed with septic disseminated intravascular coagulation (DIC) by the diagnostic criteria for acute DIC. MATERIALS AND METHODS: A total of 88 sepsis patients who had received inpatient hospital care during the period from January 2000 through December 2008 were divided into two groups, an antithrombin group and a non-antithrombin group, to study the outcomes. Furthermore, the relationship between sepsis-related factors and DIC in 44 patients was studied. RESULTS: The antithrombin group contained 34 patients, and the non-antithrombin group contained 54 patients. The outcomes were significantly better in the antithrombin group. The levels of protein C were low in DIC patients. CONCLUSION: Our results suggest that early administration of antithrombin might improve outcomes of septic DIC patients in the diagnostic criteria for Japanese Association for Acute Medicine acute DIC.
Aged
;
Disseminated Intravascular Coagulation/complications/diagnosis/*drug therapy
;
Female
;
Fibrinolytic Agents/*therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Sepsis/complications/diagnosis/*drug therapy
;
Time Factors
;
Treatment Outcome
3.Laser-cut-type versus braided-type covered self-expandable metallic stents for distal biliary obstruction caused by pancreatic carcinoma: a retrospective comparative cohort study
Koh KITAGAWA ; Akira MITORO ; Takahiro OZUTSUMI ; Masanori FURUKAWA ; Yukihisa FUJINAGA ; Kenichiro SEKI ; Norihisa NISHIMURA ; Yasuhiko SAWADA ; Kosuke KAJI ; Hideto KAWARATANI ; Hiroaki TAKAYA ; Kei MORIYA ; Tadashi NAMISAKI ; Takemi AKAHANE ; Hitoshi YOSHIJI
Clinical Endoscopy 2022;55(3):434-442
Background/Aims:
Covered self-expandable metallic stents (CMSs) are widely used for malignant distal biliary obstructions (MDBOs) caused by pancreatic carcinoma. This study compared the efficacy and safety of the laser-cut-type and braided-type CMSs.
Methods:
To palliate MDBOs caused by pancreatic carcinoma, the laser-cut-type CMSs was used from April 2014 to March 2017, and the braided-type CMSs was used from April 2017 to March 2019. The tested self-expandable metallic stents were equipped with different anti-migration systems.
Results:
In total, 47 patients received CMSs for MDBOs (24 laser-cut type, 23 braided-type). The time to recurrent biliary obstruction (TRBO) was significantly longer in the braided-type CMSs (p=0.0008), and the median time to stent dysfunction or patient death was 141 and 265 days in the laser-cut-type CMSs and braided-type CMSs, respectively (p=0.0023). Stent migration was the major cause of stent dysfunction in both groups, which occurred in 37.5% of the laser-cut-type CMSs and 13.0% of the braidedtype CMSs. There were no differences in the survival duration between the groups.
Conclusions
The TRBO was significantly longer for the braided-type CMSs with an anti-migration system than for the laser-cuttype. Stent migration tended to be less frequent with the braided-type CMSs than with the laser-cut-type CMSs.
4.Nasal Continuous Positive Airway Pressure for Carcinomatous Lymphangitis in End-stage Malignant Soft Tissue Sarcoma: A Case Report
Natsuko FUKUOKA ; Akihito TSUJI ; Yoshiki YAMAGAMI ; Hideki NISHIMURA ; Kosuke CHUJO ; Akitsu MURAKAMI ; Tetsuji YAMAMOTO
Palliative Care Research 2020;15(3):233-237
Background: In the end stage of malignant bone and soft tissue tumors with lung metastasis, it is often necessary to relieve symptoms of dyspnea due to tumor enlargement and carcinomatous lymphangitis. We report a case in which nasal continuous positive airway pressure (nasal CPAP) was effective as a palliative treatment. Case: A 66-year-old male underwent wide resection with a diagnosis soft tissue sarcoma of right femur. Four years after surgery, he was hospitalized for hilar lymph node metastasis, multiple bone metastases, and carcinomatous lymphangitis. He was treated with nasal CPAP for dyspnea, and communication was possible until the day before his death. Discussion: For end-stage respiratory symptoms, medication therapy such as morphine or steroids is often used for palliation, but often symptoms are not sufficiently improved. Nasal CPAP might be a useful treatment for palliation for rapidly progressing respiratory failure.
5.A Case of Esophageal Hiatal Hernia Presenting as Upside-Down Stomach Treated Conservatively in Which the Entire Stomach, Transverse Colon, Small Intestine, Pancreas, and Spleen Prolapsed
Emiri SUGIYAMA ; Yasuharu TOKUYAMA ; Hidenori OJIO ; Mana KAWAJIRI ; Kosuke NISHIMURA ; Kazuhiro ISHIHARA
Journal of the Japanese Association of Rural Medicine 2022;71(4):342-347
A woman in her late 80s visited a local physician complaining of nausea, loss of appetite, and constipation. She was referred to our hospital for detailed examination. Computed tomography (CT) revealed that the entire stomach, pancreas, spleen, transverse colon, and small intestine were prolapsed into the mediastinum and left thoracic cavity through the esophageal hiatus, which was dilated. Moreover, the small intestine was narrowed at the hiatus and dilated in the abdominal cavity, presenting ileus. After diagnosing type IV esophageal hiatal hernia with upside-down stomach and starting conservative treatment, the ileus improved and oral intake was resumed. Subsequent CT showed continued prolapse of the pancreas, spleen, transverse colon, small intestine, and entire stomach, but CT taken 5 years earlier had shown similar findings of prolapse. Thus, we decided not to perform surgery and instead opted for close follow-up after discharge. The patient is well without any symptoms of obstruction as of 1.5 years after discharge.